Navigating the New CFIUS Regulations for Investments with U.S. Partners

8:30 AM - 8:55 AM (EST), Tuesday, February 11, 2020 ・ Julliard Complex
New national security regulations in the United States are changing the landscape for cross-border investments in biotechnology. In January 2020, new regulations were published for foreign investors into U.S. companies who now need to file with the Committee on Foreign Investment in the United States (CFIUS) to approve covered foreign investment transactions. This session will update market participants on the evolving national security review process and its impact on the biotechnology industry, as well as consider how additional rules may impact future business development and investment opportunities.
Vice President, Tax Policy, Emerging Companies
Biotechnology Innovation Organization (BIO)
Wiley Rein LLP